Australia markets close in 2 hours 52 minutes

BioCryst Pharmaceuticals, Inc. (BCRX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.34+0.24 (+4.71%)
At close: 04:00PM EDT
5.55 +0.21 (+3.93%)
After hours: 07:59PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-208,585
-226,539
-247,116
-184,062
-182,814
Depreciation & amortisation
1,556
1,655
1,437
777
748
Stock-based compensation
55,260
55,615
44,701
34,640
14,794
Change in working capital
-53,265
-32,401
-58,945
8,124
26,875
Inventory
-2,801
-1,450
-12,423
-8,767
-7,039
Accounts payable
-
-16,806
-22,360
39,412
17,355
Other working capital
-103,556
-97,309
-163,201
-144,542
-135,622
Other non-cash items
85,213
86,225
99,850
54,204
3,325
Net cash provided by operating activities
-101,313
-95,141
-161,850
-142,157
-135,108
Cash flows from investing activities
Investments in property, plant and equipment
-2,243
-2,168
-1,351
-2,385
-514
Purchases of investments
-453,779
-514,407
-244,283
-10,012
-49,818
Sales/maturities of investments
460,389
385,077
117,396
28,201
43,476
Net cash used for investing activities
4,367
-131,498
-128,238
15,804
-6,856
Cash flows from financing activities
Debt repayment
-242,007
-241,617
0
0
-52,420
Common stock issued
353
342
190
50,060
93,279
Other financing activities
-
-34,580
-
293,874
122,600
Net cash used provided by (used for) financing activities
26,360
32,485
88,027
359,668
300,589
Net change in cash
-70,468
-193,792
-201,495
233,386
158,625
Cash at beginning of period
156,599
306,239
507,734
274,348
115,723
Cash at end of period
86,013
112,447
306,239
507,734
274,348
Free cash flow
Operating cash flow
-101,313
-95,141
-161,850
-142,157
-135,108
Capital expenditure
-2,243
-2,168
-1,351
-2,385
-514
Free cash flow
-103,556
-97,309
-163,201
-144,542
-135,622